SCHEMBL4957989

SCHEMBL4957989

NC1SC=CN1C(=O)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.39
BCHE P06276 2/20 0.39
HPGD P15428 1/20 0.38
ATM Q13315 1/20 0.38
MAPT P10636 3/20 0.38
TSHR P16473 3/20 0.38
CYP2C19 P33261 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
POLB P06746 1/20 0.38
CYP3A4 P08684 1/20 0.38
PARP1 P09874 1/20 0.38
RECQL P46063 1/20 0.38
BLM P54132 1/20 0.38
PMP22 Q01453 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
CHRNB2 P17787 1/20 0.37
CHRNB4 P30926 1/20 0.37
CHRNA3 P32297 1/20 0.37
CHRNA7 P36544 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27459490 0.79 P2RX4 (0.40) ACHEBCHEHPGDATMMAPT
Bromide SCHEMBL27613563 0.77 ACHE (0.44) ACHEBCHEHPGDATMMAPT
SCHEMBL27903597 0.72
SCHEMBL27704295 0.71
Urea SCHEMBL29227693 0.67 SIRT1 (0.33) HPGDALDH1A1RAB9A
SCHEMBL8772492 0.67 MAPT (0.37) ACHEHPGDMAPTTSHRCYP2C19
SCHEMBL3650639 0.64 CHRNB2 (0.61) ACHEHPGDL3MBTL1BLMCHRNB2
SCHEMBL27672167 0.63 BCHE (0.48) ACHEBCHEHPGDMAPTTSHR
SCHEMBL12256049 0.63 TSHR (0.55) ACHEBCHEHPGDMAPTTSHR
Hydrazine SCHEMBL7816958 0.62 TSHR (0.43) ACHEBCHEHPGDMAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200371-A1 THIAZOLE AND THIADIAZOLE INHIBITORS OF TYROSINE PHOSPHATASES IMPINJ, INC. 2008-08-21 US disclosed
US-7381736-B2 Thiazole and thiadiazole inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. (US) 2008-06-03 US disclosed
US-20060194768-A1 Thiazole and thiadiazole inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2006-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194768-A1 Thiazole and thiadiazole inhibitors of tyrosine phosphatases PTPN1, PTPN5, PTPN18 ACHE 3469/4885BCHE 4715/4885HPGD 2505/4885
US-20080200371-A1 THIAZOLE AND THIADIAZOLE INHIBITORS OF TYROSINE PHOSPHATASES PTPN1, PTPN5, PTPN18 ACHE 3469/4885BCHE 4715/4885HPGD 2505/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.